Safety and Tolerability of GX-P1 in Healthy Male Volunteers

NCT04298749 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Autoimmune Diseases

Interventions

DRUG: GX-P1 or Placebo (dose level 1)
DRUG: GX-P1 or Placebo (dose level 2)
DRUG: GX-P1 or Placebo (dose level 3)

Sponsor

Genexine, Inc.